NCT01177826已完成不适用
Case-control Study to Evaluate the Vaccine Effectiveness of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Human Rotavirus (HRV) Vaccine (Rotarix™) Against Community-acquired Rotavirus Severe Gastroenteritis (RV SGE) Among Hospitalised Children Born After 1 October 2006, in Belgium
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 643
- 试验地点
- 1
- 主要终点
- Occurrence of PCR-confirmed rotavirus (RV) severe gastroenteritis (SGE) in children fully vaccinated with Rotarix or in unvaccinated children
研究概览
简要总结
The purpose of this study is to assess vaccine effectiveness of Rotarix in preventing rotavirus severe gastroenteritis among hospitalized infants, in Belgium.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 14 Weeks 至 5 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •For confirmed cases:
- •A male or female child born after 01 October 2006 and at least 14 weeks of age at the time of hospital admission.
- •Child admitted at the study hospital for SGE during the study period.
- •Onset of SGE ≤ 14 days prior to admission.
- •Written informed consent obtained and signed from the parent or guardian of the child.
- •Stool samples collected during the first 48 hours of hospitalisation and then tested positive for RV by PCR.
- •For controls:
- •A male or female child born after 01 October 2006 and at least 14 weeks of age at the time of the hospital admission or visit to the hospital outpatient clinic.
- •Hospitalised or visiting the hospital outpatient clinic for non-GE causes at the same hospital during the same time-period, as the probable case.
- •Born within ±2 weeks from the date of birth of the case. If the list of children born within ±2 weeks is exhausted, then the range will be extended to ±4 weeks. In case a suitable control is not found even then, the range will be extended to ±6 weeks.
- •Written informed consent obtained and signed from the parent or guardian of the child.
排除标准
- •Child has previously participated as a case or a control in this study, either in the same hospital or in another study hospital.
- •Onset of SGE >48 hours after admission to the hospital (nosocomial infections).
- •Child with a condition where rotavirus vaccination would be contraindicated.
- •For controls:
- •Child has participated in the past as a case or control in this study, either in the same hospital or in another study hospital.
- •Child who has symptoms of GE/ SGE during current hospital stay/ visit to the hospital outpatient clinic or on the day of interview of his/her parent or guardian.
- •Child with a condition where rotavirus vaccination would be contraindicated.
结局指标
主要结局
Occurrence of PCR-confirmed rotavirus (RV) severe gastroenteritis (SGE) in children fully vaccinated with Rotarix or in unvaccinated children
时间窗: More than 14 days after receipt of vaccine
次要结局
- Occurrence of RV serotypes among hospitalized PCR-confirmed RV SGE children born after 01 October 2006 and at least 14 weeks of age(Average time frame: 1 year from the date of subject enrolment)
- Occurrence of SGE due to RV among children born after 01 October 2006, at least 14 weeks of age and admitted to hospital(Average time frame: 1 year from the date of subject enrolment)
- Occurrence of co-infections with other organisms among children born after 1 October 2006, at least 14 weeks of age and hospitalized with PCR-confirmed RV SGE(Average time frame: 1 year from the date of subject enrolment)
- Occurrence of PCR-confirmed RV SGE in children who received one or two doses of Rotarix or in unvaccinated children(More than 14 days after receipt of vaccine)
- Occurrence of PCR-confirmed RV SGE in children who received at least one dose of Rotarix or Rotateq in unvaccinated children(More than 14 days after receipt of vaccine)
- Occurrence of PCR-confirmed RV SGE by age and month of year, among children born after 01 October 2006, at least 14 weeks of age and admitted to the hospital(Average time frame: 1 year from the date of subject enrolment)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe GastroenteritisInfections, RotavirusNCT01978223GlaxoSmithKline
已完成
不适用
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in BrazilRotavirus GastroenteritisNCT01177657GlaxoSmithKline1,944
已完成
不适用
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in InfantsRotavirus Severe GastroenteritisNCT00655187GlaxoSmithKline1,270
已完成
4 期
Pilot Study of the Rotavirus Vaccine in Infants With Intestinal FailureRotavirus VaccinesIntestinal FailureNCT00995813Seattle Children's Hospital15
已完成
3 期
Dose Confirmation Efficacy Study (V260-007)Rotavirus InfectionsNCT00092443Merck Sharp & Dohme LLC1,312